Company Search:
Advanced Search
Sponsored Links
Dechra Pharmaceuticals PLC Company Snapshot
Dechra Pharmaceuticals PLC operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dechra Pharmaceuticals PLC with three other pharmaceutical manufacturers in Europe: BTG Plc (2019 sales of £698.23 million [US$894.02 million] of which 69% was Product), Abcam PLC (£259.90 million [US$332.78 million] of which 100% was Sales of antibodies and related products), and Dottikon ES Holding AG which is based in Switzerland (147.71 million Swiss Francs [US$148.60 million] of which 100% was The pharmaceutical).

Sales Analysis. Dechra Pharmaceuticals PLC reported sales of £481.80 million (US$616.90 million) for the fiscal year ending June of 2019. This represents an increase of 18.3% versus 2018, when the company's sales were £407.10 million. Sales at Dechra Pharmaceuticals PLC have increased during each of the previous five years (and since 2014, sales have increased a total of 149%). Sales of Na Pharmaceuticals saw an increase of 19.8% in 2019, from £148.40 million to £177.80 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dechra Pharmaceuticals PLC
  Stock Performance Chart for Dechra Pharmaceuticals PLC
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 2,622.00p
(Figures in Pounds Sterling)
1 Week -0.2%   13 Weeks 1.9%  
4 Weeks -10.2%   52 Weeks 20.6%  
Dechra Pharmaceuticals PLC Key Data:
  Ticker: DPH Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 481,800,000
(Year Ending Jan 2020).
Employees: 1,731
  Currency: Pounds Sterling Market Cap: 2,691,525,004
  Fiscal Yr Ends: June Shares Outstanding: 102,651,602
  Share Type: Ordinary Closely Held Shares: 5,390,548
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.